Cargando…
Biological sex is associated with heterogeneous responses to IL-6 receptor inhibitor treatment in COVID-19—A retrospective cohort study
COVID-19 is associated with higher inflammatory markers, illness severity and mortality in males compared to females. Differences in immune responses to COVID-19 may underpin sex- specific outcome differences. We hypothesised that anti-IL-6 receptor monoclonal antibodies are associated with heteroge...
Autores principales: | Stein, Dan F., Foley, Conor, Byott, Matt, Nastouli, Eleni, Ambler, Gareth, Arulkumaran, Nishkantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439929/ https://www.ncbi.nlm.nih.gov/pubmed/37598275 http://dx.doi.org/10.1038/s41598-023-40744-y |
Ejemplares similares
-
Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021) -
Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
por: Snow, Timothy A.C., et al.
Publicado: (2021) -
Influence of IL-6 levels on patient survival in COVID-19
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021) -
Haemodialysis and peritoneal dialysis patients admitted to intensive care units
por: Arulkumaran, Nishkantha, et al.
Publicado: (2007) -
Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2
por: Cherkaoui, Dounia, et al.
Publicado: (2022)